Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $673 - $759
-3 Reduced 17.65%
14 $3,000
Q4 2021

Mar 09, 2022

BUY
$198.88 - $227.6 $3,380 - $3,869
17 New
17 $678,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Karlinski Andrew C Portfolio

Follow Karlinski Andrew C and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Karlinski Andrew C, based on Form 13F filings with the SEC.

News

Stay updated on Karlinski Andrew C with notifications on news.